Cyltezo

Active Ingredient(s): Adalimumab-adbm
FDA Approved: * August 25, 2017
Pharm Company: * BOEHRINGER INGELHEIM
Category: Immunosuppressive

Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[5][6][7] It is administered by injection under the skin.[5] Common side effects include upper respiratory tract infections, pain at the site o... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

CyltezoCyltezo Kit
NDC: 0597-0370
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
CyltezoCyltezo Kit
NDC: 0597-0375
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
CyltezoCyltezo Kit
NDC: 0597-0400
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
CyltezoCyltezo Kit
NDC: 0597-0405
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
CyltezoCyltezo Kit
NDC: 0597-0485
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
CyltezoCyltezo Kit
NDC: 0597-0495
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients